Skip to main content

Cyclandelate Disease Interactions

There are 3 disease interactions with cyclandelate.

Moderate

Cyclandelate (applies to cyclandelate) coronary artery/CV disease

Moderate Potential Hazard, High plausibility. Applicable conditions: Cerebral Vascular Disorder, Ischemic Heart Disease

The use of cyclandelate produces vasodilatory effects which may compromise blood flow to coronary arteries or the cerbrovasculature. Therapy with cyclandelate should be administered cautiously to patients with coronary artery disease or cerebrovascular disease.

References

  1. (2001) "Product Information. Cyclospasmol (cyclandelate)." Wyeth-Ayerst Laboratories
Moderate

Cyclandelate (applies to cyclandelate) glaucoma

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Glaucoma/Intraocular Hypertension

The use of cyclandelate has been associated with an increase in intraocular pressure. Therapy with cyclandelate should be administered cautiously in patients with glaucoma.

References

  1. (2001) "Product Information. Cyclospasmol (cyclandelate)." Wyeth-Ayerst Laboratories
Moderate

Cyclandelate (applies to cyclandelate) prolonged bleeding

Moderate Potential Hazard, High plausibility.

The use of high doses of cyclandelate has been associated with prolonged bleeding in animal studies. Therapy with cyclandelate should be administered cautiously in patients with active bleeding or a bleeding tendency.

References

  1. (2001) "Product Information. Cyclospasmol (cyclandelate)." Wyeth-Ayerst Laboratories

Cyclandelate drug interactions

There are 91 drug interactions with cyclandelate.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer